Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Mymetics Corp. (MYMX : OTC)
 
 • Company Description   
Mymetics main research efforts have been concentrated in the prevention and treatment of the AIDS virus. All of Mymetics activities have been conducted in Europe.

Number of Employees: 8

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.06 Daily Weekly Monthly
20 Day Moving Average: 54,712 shares
Shares Outstanding: (millions)
Market Capitalization: $ (millions)
Beta: 0.38
52 Week High: $0.08
52 Week Low: $0.03
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -19.84% -12.49%
12 Week % %
Year To Date 78.79% 111.77%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
Route de la Corniche 4
-
Epalinges,V8 CH-1066
CHE
ph: 011-41-21-653-4535
fax: 41-21-653-2473
info@mymetics.com http://www.mymetics.com
 
 • General Corporate Information   
Officers
Ronald Kempers - Chief Executive Officer
Ulrich Burkhard - Director
Ernest Stern - Director
Thomas Staehelin - Director
Sylvain Fleury - Director

Peer Information
Mymetics Corp. (CORR.)
Mymetics Corp. (RSPI)
Mymetics Corp. (CGXP)
Mymetics Corp. (BGEN)
Mymetics Corp. (GTBP)
Mymetics Corp. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 62856A102
SIC: 2836
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 12/01/21
Next Expected EPS Date: 05/17/22
Share - Related Items
Shares Outstanding:
Most Recent Split Date: (:1)
Beta: 0.38
Market Capitalization: $ (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 05/17/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -78.22%
vs. Previous Quarter: -35.05%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -
12/31/21 - -60.28
09/30/21 - -56.77
Current Ratio
03/31/22 - -
12/31/21 - 0.01
09/30/21 - 0.02
Quick Ratio
03/31/22 - -
12/31/21 - 0.01
09/30/21 - 0.02
Operating Margin
03/31/22 - -
12/31/21 - -1,064.98
09/30/21 - -700.52
Net Margin
03/31/22 - -
12/31/21 - -1,064.98
09/30/21 - -700.52
Pre-Tax Margin
03/31/22 - -
12/31/21 - -1,099.41
09/30/21 - -706.73
Book Value
03/31/22 - -
12/31/21 - -
09/30/21 - -
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©